Kamrun Nahar is grateful to the Japan Government Ministry of Education, Culture, Sports, Science, and Technology (MEXT) for financial support
Q5: What innovations are expected in the GLP-1 medication space
Furthermore, a prespecified analysis of the SELECT trial presented at the European Congress of Obesity 2024 revealed that the magnitude of this treatment effect with semaglutide was independent of the extent of achieved weight loss 32
This contrasts with obesity, in which fatty accumulation is global, affecting the hands and feet as well
The continued demand for chromium picolinate products reflects its long history of use, broad research base, and relevance to glucose metabolismfocused formulations
For the study, researchers looked at the health data of 41,222 adults who were overweight or obese and had been prescribed one of the two drugs for the first time